DGAP-CMS: Fresenius Medical Care AG & Co. KGaA: Release of a capital market information
DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
- Share buy-back - 4th Interim Report
In the period from July 8, 2019 until and including July 12, 2019, a total of 234,300 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.
The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange:
The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including July 12, 2019 therefore amounts to 930,537 shares.
Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA
Bad Homburg v.d.H., July 12, 2019
15.07.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Company:||Fresenius Medical Care AG & Co. KGaA|
|61352 Bad Homburg|
|End of News||DGAP News Service|
Passende emittierte Barrier Reverse Convertibles
|Basiswert||Valor||Fälligkeitstag||Maximale Rendite p.a.|
|BASF SE / Fresenius Medical Care AG & Co. KGaA (St) / Siemens AG||47334775||26.10.2020||8.85 %|